chr1-145686641-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001201325.2(PDZK1):c.296G>A(p.Arg99Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000332 in 1,595,262 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 8/12 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001201325.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDZK1 | NM_001201325.2 | c.296G>A | p.Arg99Gln | missense_variant | 3/9 | ENST00000417171.6 | NP_001188254.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDZK1 | ENST00000417171.6 | c.296G>A | p.Arg99Gln | missense_variant | 3/9 | 1 | NM_001201325.2 | ENSP00000394485.1 | ||
PDZK1 | ENST00000344770.6 | c.296G>A | p.Arg99Gln | missense_variant | 3/9 | 5 | ENSP00000342143.2 | |||
PDZK1 | ENST00000451928.6 | c.296G>A | p.Arg99Gln | missense_variant | 3/7 | 2 | ENSP00000403422.2 | |||
PDZK1 | ENST00000443667.1 | c.296G>A | p.Arg99Gln | missense_variant | 4/6 | 5 | ENSP00000409291.1 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151664Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000496 AC: 11AN: 221776Hom.: 0 AF XY: 0.0000665 AC XY: 8AN XY: 120220
GnomAD4 exome AF: 0.0000333 AC: 48AN: 1443480Hom.: 0 Cov.: 27 AF XY: 0.0000488 AC XY: 35AN XY: 717642
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151782Hom.: 0 Cov.: 29 AF XY: 0.0000270 AC XY: 2AN XY: 74150
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at